Used in research and development for targeting PMEL17, a protein involved in melanin synthesis, this antibody serves as a critical tool in studying melanocyte biology and melanoma. It enables specific detection and isolation of PMEL17 in assays such as Western blotting, immunohistochemistry, and flow cytometry. Due to its high specificity, it supports the validation of therapeutic antibodies and the development of targeted treatments for pigmentation disorders and melanoma. It is also employed as a reference standard in comparative studies evaluating anti-melanoma drug candidates.